“Global Insight Services company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
The Asthma Spacers Market size was over USD 1.78 billion in 2023, and it is anticipated to grow at a CAGR of 6.3% during the forecast period.
View The Full Report Here –https://www.globalinsightservices.com/reports/asthma-spacers-market
Both children and adults can get asthma, which is a chronic condition. Asthma results from a restricted airway in the lungs caused by inflammation and tight muscles around the airways. The typical symptoms of asthma include wheezing, chest tightness, coughing, and shortness of breath. A holding chamber in the form of a tube is an asthma spacer. Less medication enters the mouth and throat thanks to the spacers’ help getting it straight to the lungs. The metered-dose inhaler, often known as a puffer, is very helpful while utilizing the asthma spacer (MDI). The appropriate administration of aerosolized medication is aided by a spacer.
Market Trends and Drivers
The rising prevalence of respiratory disorders, which is a major element fueling the expansion of the worldwide asthma spacer market, is the cause of the rising demand for asthma spacers. An increased chance of having asthma is associated with several variables, including allergic diseases including eczema and rhinitis (hay fever), urbanization, exposure to tobacco smoke, and viral respiratory infections. For instance, the World Health Organization (WHO) estimates that in 2019, asthma killed over 461,000 people and impacted nearly 262 million people. Furthermore, according to NHS England, in 2023, about 2-3% of consultations in primary care were related to asthma. It affects day-to-day activities, including employment and schooling, and causes 200,000 bed days and 60,000 hospital admissions annually in the UK (NICE). Three individuals in the UK lose their lives to asthma attacks every day, and someone experiences a potentially fatal asthma episode every ten seconds.
Market Restraints and Challenges
The development of the global market for asthma spacers during the forecast period would be significantly hampered by alternative treatments for asthma. Bronchial thermoplasty is an effective asthma treatment. It is a tried-and-true alternative asthma treatment. For instance, the Alair BT System study, which included patients treated with it, reported encouraging results in May 2017 from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma (PAS2) study, according to Boston Scientific, a manufacturer of medical devices. The research results demonstrated that BT decreased problems in adult patients with severe chronic asthma.
Unlock Growth Potential in Your Industry – Get Your Sample Report Now@https://www.globalinsightservices.com/request-sample/GIS10441
Major Players in the Global Asthma Spacers Market
The major players studied in the report are Cipla Inc., PARI GmbH, Koninklijke Philips N.V., GSK plc., HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, AGPMED Rossmax International Ltd., and Teleflex among others.
COVID-19 Impact
The most recent epidemic was the coronavirus (COVID-19) pandemic, which was first identified on December 31, 2019, in Wuhan, China. On March 11, 2020, the World Health Organization classified COVID-19 as a pandemic. Worldwide reports of coronavirus (COVID-19) infections and deaths reached approximately 225 million cases and 4.63 million, respectively, as of September 14, 2021, according to the World Health Organization’s Coronavirus Disease (COVID-19) Weekly Epidemiological Update. The financial standing of companies across all industries has been harmed by the coronavirus (COVID-19) outbreak and lockdown in numerous nations throughout the world. One industry that has been severely damaged by the pandemic is the private healthcare sector. The private healthcare industry is now financially burdened as a result of the lockdown in several nations.
Recent Developments
- Recently, in January 2024, Aiolos Bio, Inc. and GSK plc signed an agreement under which GSK will acquire Aiolos for an upfront payment of $1 billion and up to $400 million in certain success-based regulatory milestone payments. The clinical-stage biopharmaceutical company Aiolos Bio, Inc. is focused on treating patients who have unmet treatment needs for certain inflammatory and respiratory conditions.
- In July 2023, the pharmaceutical company Lupin introduced a pressurized metered dose inhaler in Germany to treat asthma and chronic obstructive pulmonary disease (COPD). Luforbec has been introduced in Germany by Hormosan Pharma GmbH, a wholly-owned subsidiary of the business.
- In July 2020, AstraZeneca and Honeywell are collaborating on the creation of next-generation respiratory inhalers using propellent HFO-1234ze, which has up to 99.9% less Global Warming Potential than propellants currently used in respiratory treatment.
- In April 2019, Cipla announced the launch of Niveoli. The product is India’s first beclomethasone-formoterol combination hydrofluoroalkane inhaler for adults, indicated against asthma and COPD.
Unlock Insights: Request Your Customizable Report Today@https://www.globalinsightservices.com/request-customization/GIS10441
Global Asthma Spacer Market Segmentation
By Type
- Aerochamber
- Optichamber
- Volumatic
- InspirEase
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Optical Stores
- Online Pharmacies
Buy Now-https://www.globalinsightservices.com/checkout/single_user/GIS10441
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.